Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nicotrol TD launch

This article was originally published in The Tan Sheet

Executive Summary

Pharmacia's OTC nicotine transdermal three-step dosing system will launch this fall. Prior one-step Nicotrol patch may or may not be discontinued, firm says. Ad agency BBDO (New York), currently assigned to Rogaine, will handle ad campaign. Pharmacia says ads will focus on Nicotrol's 16-hour use period, which some consumers may prefer over 24-hour period for GlaxoSmithKline's NicoDerm CQ. Company says it has no plans for OTC switch of Nicotrol inhaler, nasal spray. Pharmacia received FDA approval of its NDA for Nicotrol TD March 21 (1"The Tan Sheet" March 25, 2002, p. 3)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS093830

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel